Wikipedia -WSS

Wikipedia

author：focus 2025-09-29 16:34:23 - browse：1

Three boxes of Breyanzi on a dark blue background — biotech coverage from STAT — The FDA is looking into adverse events involving a number of CAR-T therapies, including Breyanzi. Illustration: STAT; Source: Business Wire

The Food and Drug Administration said Tuesday that it is investigating whether CAR-T therapy, which uses genetically modified white blood cells to attack tumors, can in rare cases cause lymphoma, a blood cancer.

“Although the overall benefits of these products continue to outweigh their potential risks for their approved uses, FDA is investigating the identified risk of T cell malignancy with serious outcomes, including hospitalization and death, and is evaluating the need for regulatory action,” the agency said in a statement.

The agency noted that it is investigating reports of T cell lymphoma, including cancer cells carrying the engineered T cells, in patients who received CAR-T therapy. Experts in the field, which has produced multiple approved products to treat blood cancer, expressed surprise and puzzlement at the announcement, saying that they had not previously seen data about the risk.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Annovis Bio delivers candor, but not confidence, on Parkinson’s study

hotspot

WSS

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Ed Silverman on new gene therapies, biosimilars, coffee, and more

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

STAT readers on older presidents, polypills, Medicare, and more

6 phony surgeries that take placebo to the extreme

6 phony surgeries that take placebo to the extreme

focus

Wikipedia

entertainment

At least 13 dead in Texas as scorching temps continue

He's a Nobel laureate. Critics say he was misleading on Covid

What does generative AI mean for health care? We asked experts

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Apple is now the first public company to be valued at $3 trillion

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Supreme Court strikes down use of affirmative action

R1 RCM gets $5.8 billion buyout offer from private equity firm

Novavax promises a turnaround & Lilly roils the obesity market

Why palliative psychiatry is worth discussing

explore

Alabama IVF ruling threatens families facing fatal genetic disease

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

New documents shed light on MD Anderson Cancer Institute feud

NIH study of ME/CFS points to clear biological hallmarks

focus

hotspot

entertainment

Wikipedia